ÌìÃÀ´«Ã½

Mount Sinai Cardiologists Present Late Breaking Trials and Breakthrough Studies at American College of Cardiology Scientific Sessions (ACC.25)

 Experts also available for interviews on trending topics and studies

Newswise — (New York, NY – March 25, 2025) –Top experts from Mount Sinai Fuster Heart Hospital in New York City will present late breaking trials and other landmark studies at ACC.25 taking place March 29-31 in Chicago. I have included details on their notable presentations below. We have two late-breaking clinical trials, and research on AI as it relates to the field of cardiology care. Please let me know if need to coordinate interviews involving their work. Our experts are also available to comment on trending topics, and outside studies.

*LATE BREAKING CLINICAL TRIALS* EMBARGOED UNTIL DAY/TIME OF PRESENTATION

The Main Results Of The Phase 3 Reverse-it Trial
Date/Time/Location: Saturday, March 29, 11:45am (Central Time) – Main Tent
Presenter: Deepak L. Bhatt, MD, MPH, MBA, Director of Mount Sinai Fuster Heart Hospital and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine at Mount Sinai
Session:103 – Late-Breaking Clinical Trials II

Impact Of Intravascular Imaging Guidance On Percutaneous Coronary Intervention Of Severely Calcified Lesions: The ECLIPSE Trial
Date/Time/Location: Monday, March 31, 1:24pm (Central Time) – S100B
Presenter: Gregg W. Stone, MD, Director of Academic Affairs for the Mount Sinai Health System and Professor of Medicine (Cardiology), and Population Health Science and Policy, at Icahn Mount Sinai
Session: 434 - Late-Breaking Clinical Trials – Clinical and Investigative Horizons II

MODERATED POSTERS

Diabetes and Plaque Stabilization in Patients Treated with Evolocumab: Insights from the YELLOW III trial
Presenter: Keisuke Yasumura, MD, Assistant Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai Date/Time/Location: Saturday, March 29, 3:54pm (Central) – Moderated Poster Theater 4
Session: 933 - Intracoronary Imaging, Hemodynamics and Microvascular Function

Sex Differences in Plaque Stabilization in Patients Treated with Evolocumab: Mechanistic Insights from the YELLOW III Trial Presenter: Keisuke Yasumura, MD, Assistant Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai
Date/Time/Location: Saturday, March 29 4:06pm (Central) – Moderated Poster Theater 4
Session: 933 - Intracoronary Imaging, Hemodynamics and Microvascular Function

Title: Lipoprotein (a) and Coronary Atherosclerosis in Intracoronary Imaging - YELLOW – Lp(a) Study
Presenter: Chen Gurevitz, MD, Cardiology Fellow at the Mount Sinai Fuster Heart Hospital
Date/Time/Location: Sunday, March 30, 12:54pm (Central) – Moderated Poster Theater 2
Session: 961 - Lipoprotein (a): New Frontiers in Risk Reduction

The Impact of Adherence to LDL-C Lowering Therapies on Cardiovascular Events Among Adults with Atherosclerotic Cardiovascular Disease, Heterozygous Familial Hypercholesterolemia and Primary Hyperlipidemia
Presenter: Robert S. Rosenson MD, Director of the Metabolism and Lipids Program for Mount Sinai Fuster Heart Hospital Date/Time/Location: Monday, March 31, 11:42am (Central) – Moderated Poster Theater 2
Session: 1006 – Lipids and Lipoproteins: New Insights on Cardiovascular Cornerstones

The Community-Based Heart Failure Alliance Program: Providing Multidisciplinary Care for Minority Patients with Heart Failure, Diabetes and Obesity
Presenter: Johanna Contreras, MD, Associate Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai   Date/Time/Location: Monday, March 31, 10:36am (Central) – Moderated Poster Theater 6
Session: 995 Racial and Geographic Disparities and the Effect of Policy and Cost on Heart Failure Management – Heart Failure and Cardiomyopathies

High LP(A) Increases Thrombogenicity Particularly in Patients with RS3798220-CSNP 
Presenter: Chen Gurevitz, MD, Cardiology Fellow at the Mount Sinai Fuster Heart Hospital
Date/Time/Location: Sunday, March 30, 1:06pm (Central) – Moderated Poster Theater 2
Session: 961 Lipoprotein (a): New Frontiers in Risk Reduction

Sex-Related Clinical Differences and Disparities in Patients with Acute Myocardial Infarction-Related Cardiogenic Shock Undergoing Percutaneous Coronary Intervention
Presenter: Madison Edens, MD, Cardiology Fellow at the Mount Sinai Fuster Heart Hospital
Date/Time/Location: Sunday, March 30, 12:12pm (Central) – Moderated Poster Theater 4
Session: 978 – Coronary/Peripheral and Structural Interventions

Prevalence and Prognostic Impact of High Ischemic Risk Criteria in Chronic Coronary Syndrome Patients Undergoing PCI Presenter: Angelo Oliva, MD, Postdoctoral Research Fellow at the Center for Interventional Cardiovascular Research and Clinical Trials at the Icahn School of Medicine at Mount Sinai
Date/Time/Location: Monday, March 31, 11:42am (Central) – Moderated Poster Theater 4
Session: 1008 – Coronary/Peripheral and Structural Interventions

Echocardiographic Changes Post-Transcatheter Aortic Valve Replacement by Sex and Subtype of Low-Flow Severe Aortic Stenosis Presenter: Eileen Galvani, Internal Medicine Resident at the Icahn School of Medicine at Mount Sinai
Date/Time/Location: Monday, March 31, 10:36am (Central) – Moderated Poster Theater 3
Session: 907 – Multimodal Imaging

Aortic Valve Calcification as a Predictor of Transcatheter Aortic Valve Replacement Outcomes across the Spectrum of Low-Flow, Low-Gradient Aortic Stenosis
Presenter: Yash Prakash, Internal Medicine Resident at the Icahn School of Medicine at Mount Sinai
Date/Time/Location: Saturday, March 29, 9:30am (Central) – Moderated Poster Theater 3
Session: 992- TAVR Outcomes

POSTERS

A Multicenter, Prospective Cohort Pilot Study on the Clinical Implementation and Utilization of an AI-Based ECG Tool for HCM Detection and Care Coordination
Presenter: Joshua Lampert, MD, Assistant Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai and Director of Machine Learning at the Mount Sinai Fuster Heart Hospital
Date/Time/Location: Saturday, March 29, 9:30am (Central) – Board #179
Session: 1029 – Heart Failure and Cardiomyopathies  

Utilizing Custom AI Voice Healthcare Assistant to Automate Patient Pre-Operative Onboarding
Presenter: Derek A. Pineda, FNP, CCRN, RCIS, AACC, Mount Sinai Fuster Heart Hospital
Date/Time/Location: Sunday, March 30, 12pm (Central) – Board #44
Session: 1166 - Featured Fields 08

Subclinical Atherosclerosis Detection: The Importance of Imaging in Low and Borderline Risk Populations
Presenter: Anna Mueller, Internal Medicine Resident at the Icahn School of Medicine at Mount Sinai
Date/Time/Location: Monday, March 31, 10:30am (Central) – Board #22
Session: 1243 – Cardiovascular Disease Prevention

Cardiovascular Disease Screening: Treating the Disease Rather than the Risk for Disease
Presenter: Anna Mueller, Internal Medicine Resident at the Icahn School of Medicine at Mount Sinai
Date/Time/Location: Monday, March 31, 10:30am (Central) – Board #24
Session: 1243 – Cardiovascular Disease Prevention

Prognostic Impact of Combined Peri-Procedural Inflammatory Markers in Patients Undergoing Percutaneous Coronary Intervention
Presenter: Angelo Oliva, MD, Postdoctoral Research Fellow at the Center for Interventional Cardiovascular Research and Clinical Trials at the Icahn School of Medicine at Mount Sinai
Date/Time/Location: Monday, March 31, 10:30am (Central) – Board 76
Session: 1247 - Ischemic Heart Diseases 12

Triglyceride-Glucose Index as a Predictor of Adverse Cardiovascular Events in a Contemporary United States Population Undergoing Percutaneous Coronary Intervention
Presenter: Mark Shneyderman, Medical Student at the Icahn School of Medicine at Mount Sinai
Date/Time/Location: Monday, March 31, 10:30am (Central) – Board 75
Session: 1247 – Ischemic Heart Disease 

Remnant Cholesterol and Myocardial Infarction Risk in Patients Undergoing PCI
Presenter: Nicholas Pitaro, Internal Medicine Resident at the Icahn School of Medicine at Mount Sinai
Date/Time/Location: Monday, March 31, 10:30am (Central) – Board 78
Session: 1247 - Ischemic Heart Diseases 12

Neutrophil-Lymphocyte Ratio and Clinical Outcomes According to Atherosclerosic Disease Severity in Patients Undergoing PCI Presenter: Nicholas Pitaro, Internal Medicine Resident at the Icahn School of Medicine at Mount Sinai
Date/Time/Location: Monday, March 31, 12:00pm (Central) – Board 96
Session: 1265 - Coronary, Peripheral and Structural Interventions 13

Impact of Peripheral Arterial Disease on Clinical Outcomes of Patients Undergoing Complex vs. Non-Complex Percutaneous Coronary Intervention (PCI): Results from a Large U.S. Registry
Presenter: Michael Gao, Internal Medicine Resident at the Icahn School of Medicine at Mount Sinai Date/Time/Location: Sunday, March 30, 9:00am (Central) – Board 101
Session: 1130 - Coronary, Peripheral and Structural Interventions 06

Impact of Baseline Thrombocytopenia on Ischemic, Bleeding and Mortality Risk after Percutaneous Coronary Intervention
Presenter: Tushar Mishra, Interventional Cardiology Fellow at the Mount Sinai Fuster Heart Hospital
Date/Time/Location: Sunday, March 30, 3:00pm (Central) – Board 108
Session: 1213 - Coronary, Peripheral and Structural Interventions 10

Gender Disparities Among Patients Undergoing Transcatheter Aortic Valve Implantation in the United States,  2012-2021
Presenter: Johny Nicolas, Internal Medicine Resident at the Icahn School of Medicine at Mount Sinai
Date/Time/Location: Monday, March 31, 9:00am (Central) – Board 98
Session: 1233 - Coronary, Peripheral and Structural Interventions 11

Off-Label Pulmonary Valve Replacement Using the Medtronic Harmony Transcatheter Pulmonary Valve in Right Ventricle to Pulmonary Artery Homografts
Presenter: Barry Love, MD, Congenital Cardiac Catheterization Program at the Mount Sinai Kraviz Children’s Heart Center
Date/Time/Location: Monday, March 31, 9:00am (Central) – Board 91
Session: 1264 – Congenital Heart Disease

SYMPOSIUM

Interventional Cardiology, a Year-in-Review: Joint Symposium of the Society for Cardiovascular Angiography and Interventions and the American College of Cardiology
Presenter: George Dangas, MD, PhD, of Medicine (Cardiology) & Surgery (Vascular) at the Icahn School of Medicine & the Mount Sinai Hospital Date/Time/Location: Sunday, March 30, 8:00am (Central) – S501B
Session: 312 – Coronary/Peripheral and Structural Interventions

Mount Sinai Is a World Leader in Cardiology and Heart Surgery 

Mount Sinai Fuster Heart Hospital at The Mount Sinai Hospital ranks No. 4 nationally for cardiology, heart, and vascular surgery, according to U.S. News & World Report®. It also ranks No. 1 in New York and No. 6 globally according to Newsweek’s “The World’s Best Specialized Hospitals.”  

It is part of Mount Sinai Health System, which is New York City's largest academic medical system, encompassing seven hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. We advance medicine and health through unrivaled education and translational research and discovery to deliver care that is the safest, highest-quality, most accessible and equitable, and the best value of any health system in the nation. The Health System includes approximately 9,000 primary and specialty care physicians; 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 45 multidisciplinary research, educational, and clinical institutes. Hospitals within the Health System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report's® “Best Hospitals” Honor Roll for 2024-2025. 

For more information, visit  or find Mount Sinai on ,  and .

 ###